Lv3
250 积分 2022-10-27 加入
The vIGA‐AD scale for atopic dermatitis: Uptake in the past 5 years and position of the International Eczema Council
7天前
已完结
Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study
22天前
已完结
The pathogenetic role of Th17 immune response in atopic dermatitis
22天前
已完结
Biologics-Induced Immunophenotypic Cross-Switching in Patients with Psoriasis and Atopic Dermatitis
29天前
已完结
Application of biological therapies and mechanisms of immunophenotypic switching in psoriasis and atopic dermatitis
29天前
已关闭
Ixekizumab for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 52-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study
1个月前
已完结
The Bath Ankylosing Spondylitis Activity and Function Indices (BASDAI and BASFI) and their correlation with main symptoms experienced by patients with spondyloarthritis
2个月前
已完结
Pharmacokinetics, Safety, Tolerability, and Exploratory Efficacy of Upadacitinib in Children with Severe Atopic Dermatitis
3个月前
已完结
Emerging drugs for the treatment of atopic dermatitis: a focus on phase 2 and phase 3 trials
3个月前
已完结
Efficacy and safety of stapokibart (CM310) in adults with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
3个月前
已完结
皖公网安备34019202002308
